Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer

NDAQ:APHA - Post by User

Aphria Inc.

Bullboard Posts

Comment by Viking49on May 03, 2018 5:03pm

74 Views

Post# 27979344

RE:RE:RE:RE:RE:RE:Rumors

Viking49 wrote:

mmjgaadzilla wrote: What do you know... Your only quoting dry product. Did you not notice they also sold other products that also require dry product. They happen to have the largest greenhouse already in production. Your assurances don't comfort me at all.

The Exeter greenhouse was recently purchased and renovations started in April. MedReleaf has provided guidance of first harvest in the 1st quarter of. 2019. It will be a year before the greenhouse production starts hitting their financials.

And that’s the facts.

And MedReleaf better put lots of supplemental lighting in their GH or their yields will suffer. Exeter is not great for sunshine, they get lots of lake effect weather coming off of Lake Huron.

Bullboard Posts

Investor’s corner: Solving chronic pain in dogs – A significant market opportunity